164 related articles for article (PubMed ID: 33256116)
1. Specific Non-Reducing Ends in Heparins from Different Animal Origins: Building Blocks Analysis Using Reductive Amination Tagging by Sulfanilic Acid.
Mourier PAJ
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256116
[TBL] [Abstract][Full Text] [Related]
2. Building Block Analysis of ATIII Affinity Fractions of Heparins: Application to the ATIII Binding Capacity of Non-conventional 3-
Mourier P
Front Med (Lausanne); 2022; 9():841738. PubMed ID: 35514744
[TBL] [Abstract][Full Text] [Related]
3. Heparinase Digestion of 3-
Mourier P
Front Med (Lausanne); 2022; 9():841726. PubMed ID: 35433769
[TBL] [Abstract][Full Text] [Related]
4. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase.
Yu Y; Fu L; He P; Xia K; Varghese S; Dordick J; Wang H; Zhang F; Linhardt RJ
Carbohydr Polym; 2022 Nov; 295():119825. PubMed ID: 35988993
[TBL] [Abstract][Full Text] [Related]
7. A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin.
Zhang B; Shi D; Li M; Shi F; Chi L
Carbohydr Polym; 2023 Feb; 301(Pt A):120303. PubMed ID: 36436866
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Identification and Quantitation of Basic Building Blocks for Low-Molecular Weight Heparin.
Sun X; Sheng A; Liu X; Shi F; Jin L; Xie S; Zhang F; Linhardt RJ; Chi L
Anal Chem; 2016 Aug; 88(15):7738-44. PubMed ID: 27388010
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.
Sun X; Guo Z; Yu M; Lin C; Sheng A; Wang Z; Linhardt RJ; Chi L
J Chromatogr A; 2017 Jan; 1479():121-128. PubMed ID: 27923477
[TBL] [Abstract][Full Text] [Related]
10. A major common trisulfated hexasaccharide core sequence, hexuronic acid(2-sulfate)-glucosamine(N-sulfate)-iduronic acid-N-acetylglucosamine-glucuronic acid-glucosamine(N-sulfate), isolated from the low sulfated irregular region of porcine intestinal heparin.
Yamada S; Yamane Y; Tsuda H; Yoshida K; Sugahara K
J Biol Chem; 1998 Jan; 273(4):1863-71. PubMed ID: 9442018
[TBL] [Abstract][Full Text] [Related]
11. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
Wu J; Zhang C; Mei X; Li Y; Xing XH
Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802
[TBL] [Abstract][Full Text] [Related]
12. A sensitive ELISA for the detection of bovine crude heparin in porcine heparin.
Levieux A; Rivera V; Levieux D
J Immunoassay Immunochem; 2001; 22(4):323-36. PubMed ID: 11816801
[TBL] [Abstract][Full Text] [Related]
13. Chemometric analysis of porcine, bovine and ovine heparins.
Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
[TBL] [Abstract][Full Text] [Related]
14. Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases.
Mourier PA; Viskov C
Anal Biochem; 2004 Sep; 332(2):299-313. PubMed ID: 15325299
[TBL] [Abstract][Full Text] [Related]
15. Isolation of the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated blocks in heparin.
Yamada S; Murakami T; Tsuda H; Yoshida K; Sugahara K
J Biol Chem; 1995 Apr; 270(15):8696-705. PubMed ID: 7721774
[TBL] [Abstract][Full Text] [Related]
16. Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.
Alekseeva A; Casu B; Torri G; Pierro S; Naggi A
Anal Biochem; 2013 Mar; 434(1):112-22. PubMed ID: 23201389
[TBL] [Abstract][Full Text] [Related]
17. Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities.
Nader HB; Lopes CC; Rocha HA; Santos EA; Dietrich CP
Curr Pharm Des; 2004; 10(9):951-66. PubMed ID: 15078126
[TBL] [Abstract][Full Text] [Related]
18. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
[TBL] [Abstract][Full Text] [Related]
19. Sulfated oligosaccharides isolated from the deamination products of heparins.
Kosakai M; Yosizawa Z
J Biochem; 1981 Jun; 89(6):1933-44. PubMed ID: 6270073
[TBL] [Abstract][Full Text] [Related]
20. Generation of anti-factor Xa active, 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins.
Naggi A; De Cristofano B; Bisio A; Torri G; Casu B
Carbohydr Res; 2001 Dec; 336(4):283-90. PubMed ID: 11728396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
